Steve Harr
CIK: 0001627387
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sana Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Mar 9, 2026SANA
Sana Biotechnology, Inc.
Tax Payment(F)Direct11.5K shares at avg. $3.13$36K - Mar 9, 2026SANA
Sana Biotechnology, Inc.
Tax Payment(F)Direct12.8K shares at avg. $3.10$40K - Mar 7, 2026SANA
Sana Biotechnology, Inc.
Exercise(M)Direct50K shares- - Mar 6, 2026SANA
Sana Biotechnology, Inc.
Exercise(M)Direct41.7K shares- - Mar 5, 2026SANA
Sana Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
900K shares- - Mar 5, 2026SANA
Sana Biotechnology, Inc.
Award(A)DirectRestricted Stock Units
200K shares- - Mar 10, 2025SANA
Sana Biotechnology, Inc.
Tax Payment(F)Direct12.8K shares at avg. $2.56$33K - Mar 7, 2025SANA
Sana Biotechnology, Inc.
Exercise(M)Direct50K shares- - Mar 6, 2025SANA
Sana Biotechnology, Inc.
Award(A)DirectRestricted Stock Units
166.7K shares- - Mar 6, 2025SANA
Sana Biotechnology, Inc.
Award(A)DirectStock Option (Right to Buy)
750K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 9, 2026 | SANA Sana Biotechnology, Inc. | Tax Payment(F) | 11,526 | $3.13 | $36,076 | Direct |
| Mar 9, 2026 | SANA Sana Biotechnology, Inc. | Tax Payment(F) | 12,819 | $3.10 | $39,739 | Direct |
| Mar 7, 2026 | SANA Sana Biotechnology, Inc. | Exercise(M) | 50,000 | - | $0 | Direct |
| Mar 6, 2026 | SANA Sana Biotechnology, Inc. | Exercise(M) | 41,666 | - | $0 | Direct |
| Mar 5, 2026 | SANA Sana Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 900,000 | - | - | Direct |
| Mar 5, 2026 | SANA Sana Biotechnology, Inc. | Award(A) Restricted Stock Units | 200,000 | - | - | Direct |
| Mar 10, 2025 | SANA Sana Biotechnology, Inc. | Tax Payment(F) | 12,820 | $2.56 | $32,819 | Direct |
| Mar 7, 2025 | SANA Sana Biotechnology, Inc. | Exercise(M) | 50,000 | - | - | Direct |
| Mar 6, 2025 | SANA Sana Biotechnology, Inc. | Award(A) Restricted Stock Units | 166,667 | - | - | Direct |
| Mar 6, 2025 | SANA Sana Biotechnology, Inc. | Award(A) Stock Option (Right to Buy) | 750,000 | - | - | Direct |
1-10 of 10 transactions
About Harr Steve
Harr Steve (SEC CIK 0001627387) files insider reports with the SEC as President & CEO of Sana Biotechnology, Inc. (SANA).
Signal8 holds 3 ownership filings by Harr Steve, all Form 4s, filed between Mar 10, 2025 and Mar 10, 2026. Those filings report 10 transactions, from Mar 6, 2025 to Mar 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Harr Steve's filings is in SEATTLE, WA.
Recent filings by Harr Steve
- Mar 9, 2026: Tax withholdings of SANA shares (2 lines, Form 4, code F).
- Mar 7, 2026: Option exercise of SANA shares (Form 4, code M).
- Mar 6, 2026: Option exercise of SANA shares (Form 4, code M).
- Mar 5, 2026: Grants or awards of SANA derivative securities (2 lines, Form 4, code A).
- Mar 10, 2025: Tax withholding of SANA shares (Form 4, code F).
Other insiders filing for Sana Biotechnology, Inc. (SANA)
- Bishop Hans Edgar, Director
- PATEL DHAVALKUMAR DHIRAJLAL, EVP, Chief Scientific Officer
- Yang Patrick Y, Director
- Rosiello Robert L., Director
- Seitz Michelle, Director
- REICIN ALISE, Director